Posted by Martin Lipton,
Wachtell, Lipton, Rosen & Katz, on Tuesday, January 27, 2015
Editor’s Note:
Martin Lipton is a founding partner of Wachtell, Lipton, Rosen
& Katz, specializing in mergers and acquisitions and matters
affecting corporate policy and strategy. This post is based on a
Wachtell Lipton memorandum by Mr. Lipton, Sabastian
V. Niles, and
Sara J. Lewis. Earlier posts by Mr. Lipton on hedge fund
activism are available
here, here and
here. Recent work from the Program on Corporate Governance
about hedge fund activism includes The
Long-Term Effects of Hedge Fund Activism by Lucian Bebchuk,
Alon Brav, and Wei Jiang (discussed on the Forum here)
and The
Myth that Insulating Boards Serves Long-Term Value by Lucian
Bebchuk (discussed on the Forum here).
For five posts by Mr. Lipton criticizing the Bebchuk-Brav-Jiang
paper, and for three posts by the authors replying to Mr. Lipton’s
criticism, see
here. |
Again in 2014, as in the two
previous years, there has been an increase in the number and intensity
of attacks by activist hedge funds. Indeed, 2014 could well be called
the “year of the wolf pack.”
With the increase in
activist hedge fund attacks, particularly those aimed at achieving an
immediate increase in the market value of the target by dismembering
or overleveraging, there is a growing recognition of the adverse
effect of these attacks on shareholders, employees, communities and
the economy. Noted below are the most significant 2014 developments
holding out a promise of turning the tide against activism and its
proponents, including those in academia. Already in 2015 there
have been several significant developments that are worth adding,
which are included in bold at the end.
-
Several institutional
investors voiced concerns about activism this year, including
Laurence Fink of BlackRock—first in March lamenting the cuts to
capital expenditures and increased debt used to fuel dividends and
share buybacks, which he views as having the potential to
“jeopardize a company’s ability to generate sustainable long-term
returns,” and then in December stating that “[s]trategies pursued by
activist investors ‘destroy jobs.’”
-
Tim Armour of Capital
Group criticized the recent wave of share buybacks, explaining that
“[w]e think companies should be run for the long-term and do not
think forced steps should be taken to maximize short-term profits at
the expense of having thriving enterprise.”
-
William McNabb of Vanguard
spoke out against the standard activist playbook of aggressively
criticizing companies once problems emerge and endorsed a more
low-key approach of engagement between directors and shareholders
aimed to prevent problems before they happen.
-
James Montier of GMO
Capital presented compelling empirical evidence that, as Jack Welch
once said, shareholder value maximization is “the dumbest idea in
the world,” and demonstrating that, ironically, it has not
benefitted shareholders themselves.
-
Even activists themselves
began to acknowledge how outlandish some of their stunts are;
Jeffrey Ubben of ValueAct, for example, who favors a more
behind-the-scenes, constructive style of activism, likened certain
recent actions by other activists to “greenmail,” called certain
activist tactics “corrupt” and accused one activist in particular of
simply “entertaining himself.”
-
In December, the
Conference Board released a must-read presentation entitled
“Activists and Short Term Corporate Behavior” that compiles data
demonstrating that capital investment by U.S. public companies has
decreased (and is less than that of private companies), that
short-term pressures are increasing and that hedge fund activism
results not in the creation of value but in transfers of value from
employees and bondholders to shareholders.
-
William Galston’s
editorial in the Wall Street Journal, “‘Shareholder Value’
Is Hurting Workers: Financiers Fixated on the Short-Term Are Forcing
CEOs into Decisions That Are Bad for the Country,” as the title
suggests, warned that activism is harming workers (pointing to the
recent break-up of Timken as a prime example) and that if short-termism
prevails, “we won’t have the long-term investments in workers and
innovation that we need to sustain a higher rate of growth.”
-
Dominic Barton, the global
managing director of McKinsey, and Mark Wiseman, the president and
CEO of the Canada Pension Plan Investment Board, joined to author an
article in the Harvard Business Review, “Focusing Capital
on the Long Term,” which suggests practical steps that major asset
owners such as pension funds, insurance firms and mutual funds can
take to minimize the detrimental effects of increased pressure from
financial markets and the resulting short-termism, which they
believe has “far-reaching consequences, including slower GDP growth,
higher unemployment, and lower return on investment for savers.”
-
A federal court in
California found “serious questions” as to whether Valeant and
Pershing Square violated the federal securities laws in connection
with their joint hostile bid for Allergan and thereby, as a
practical matter, put an end to this scheme until the issue is
resolved.
-
SEC Commissioner Daniel
Gallagher and former Commissioner (and current Stanford Law
Professor) Joseph Grundfest argued that the push for board
declassification by Harvard Law School’s Shareholder Rights
Campaign, initiated by Professor Lucian Bebchuk, was not only based
on shoddy scholarship, it actually violated federal securities law
antifraud rules. (This paper was discussed on the Forum
here.)
-
SEC Commissioner Gallagher
also called for much-needed reforms to Rule 14a-8 to “ensur[e] that
activist investors don’t crowd out everyday and long-term investors”
by repeatedly bringing costly shareholder proposals (notwithstanding
prior failures) that have little or no connection to company value.
-
The SEC took a step toward
limiting uncritical reliance on proxy advisory firms by issuing
guidance indicating that, to fulfill their fiduciary duties to
clients, investment advisers must establish and implement measures
reasonably designed both to provide sufficient ongoing oversight of
proxy advisory firms and to identify and address such firms’
conflicts of interest and errors in their voting
recommendations.
-
Economics Professor
William Lazonick argued that share buybacks can boost share prices
in the short term but ultimately disrupt income equality, job
stability and overall economic growth, and research by Barclays
cited in a Financial Times article called “Buybacks: Money
Well Spent?” provided empirical support showing that the “buyback
bonanza” indeed contributed to slower growth, including lower
earnings retention not reflected in price-to-book value.
-
A paper by Dr. Yvan
Allaire entitled “The Value of ‘Just Say No,’” and also memos by our
firm (here
and
here, the latter discussed on the Forum
here), demonstrated that an ISS client note entitled “The IRR of
No,” which argued that companies that had “just said no” to hostile
takeover bids incurred profoundly negative returns, suffered from
critical methodological and analytical flaws that undermined its
conclusions.
-
Dr. Allaire also presented
sophisticated analyses contained in three
papers (“Activist Hedge Funds: Creators of Lasting Wealth?
What Do the Empirical Studies Really Say?”; “Hedge Fund Activism and
Their Long-Term Consequences; Unanswered Questions to Bebchuk, Brav
and Jiang”; and in 2015 “Still unanswered questions (and new
ones) to Bebchuk, Brav and Jiang”), consistent with our
firm’s earlier
observations (discussed on the Forum
here), offering a devastating critique of Professor Bebchuk’s
research claiming to show that attacks by activist hedge funds did
not destroy long-term value.
-
The argument made by
Professor Bebchuk, together with Professor Robert Jackson, that
poison pills were unconstitutional was similarly
dismissed (some would say derided) as the grasping-at-straws
argument that it was and one wholly inconsistent with existing case
law. (This memorandum was discussed on the Forum
here.)
-
Delaware Supreme Court
Chief Justice Leo Strine, Jr.’s Columbia Law Review
article, “Can We Do Better By Ordinary Investors? A Pragmatic
Reaction to the Dueling Ideological Mythologists of Corporate Law,”
(discussed on the Forum
here) persuasively argued against allowing investment funds to
prevail over the carefully considered judgments of boards of
directors and at the expense of the long-term interests of the
ultimate beneficiaries whose assets such funds manage.
-
In an article entitled
“The Impact of Hedge Fund Activism: Evidence and Implications,”
Columbia Law School Professor John Coffee, Jr. rejected the
so-called empirical evidence that Professor Bebchuk uses to “prove”
that activist attacks are beneficial, and proposed various potential
reforms and private ordering techniques (such as a “window-closing”
poison pill) that could help mitigate activism’s pernicious effects.
-
In “How to Outsmart
Activist Investors,” Professors William George and Jay Lorsch of the
Harvard Business School advised companies on how to fend off
activist challenges, writing that they “remain unconvinced … that
hedge fund activism is a positive trend for U.S. corporations and
the economy.”
-
Leiden University
Professor Pavlos Masouros, in his book entitled Corporate Law
and Economic Stagnation: How Shareholder Value and Short-Termism
Contribute to the Decline of the Western Economies,
convincingly outlined the chain of political, economic and legal
events that led to the shift from a “retain and invest” corporate
strategy to a “downsize and distribute” mentality, and the
consequent stagnation in GDP growth.
-
Cornell University Law
School Professor Lynn Stout also published a book that challenges
the ideology of shareholder value maximization, the title of which
speaks for itself: The Shareholder Value Myth: How Putting
Shareholders First Harms Investors, Corporations, and the Public.
-
Oxford University
Professor Colin Mayer’s Firm Commitment: Why the Corporation Is
Failing Us and How to Restore Trust in It set forth a new
paradigm for thinking about corporations, in part to solve the
“increasing[] difficult[y] for directors to do anything other than
reflect what is perceived to be in the immediate interests of their
most influential, frequently short-term shareholders.”
-
The Delaware Court of
Chancery, in Third Point LLC v. Ruprecht,
confirmed the legitimacy of the use of poison pills—not only in the
face of an inadequate takeover offer—but also in response to an
activist threat.
-
State Street
Global Advisors issued an issuer engagement protocol that is
intended to enable State Street to better understand issuers’
business strategy, management and operations. Hopefully, this will
result in State Street supporting issuers’ long-term investment
goals and mitigate exposure to activists’ short-term demands.
-
Vanguard reviewed
their proxy voting and engagement efforts, emphasizing an approach
to governance characterized by “quiet diplomacy focused on results,”
in which voting decisions are made based on “its own analysis, not
the recommendations of third parties” and direct discussions with
companies are prioritized to “permit a more nuanced and precise
exchange of views than the blunt instrument of a shareholder vote.”
-
Two prominent
former JP Morgan deal makers announced the formation of Hudson
Executive Capital, which they described as a new type of activist
hedge fund that will collaborate with companies and their boards.
The announcement stated that Hudson will not conduct proxy fights or
issue poison-pen letters. Their goal appears to be to have Hudson
recognized as a traditional merchant bank and not an activist hedge
fund.
-
Well-known Yale
School of Management Professor Jeffrey Sonnenfeld in an article in
the January/February issue of Chief Executive said,
“Vigilant CEOs have a right, and even a duty, to resist
self-motivated activism that adds nothing. It’s worth noting that it
wasn’t so very long ago that investors who resorted to such antics
were called by the less salubrious term ‘green mailers.’”
-
Guhan Subramanian,
a Professor at both Harvard Law School and Harvard Business School
and a long-time protégé-colleague of Lucian Bebchuk, has written an
article for the March issue of the Harvard Business Review
advocating a new form of corporate governance that reflects a need
to “return to first principles rather than meander toward ‘best
practices.’” His first principle is that “Boards Should Have the
Right to Manage the Company for the Long Term.” His other
recommendations are (1) replacing quarterly earnings guidance with
long-term goals, (2) accepting staggered boards if they can be
overcome by a shareholder-approved takeover bid, (3) accepting
exclusive forum bylaws, (4) instituting meaningful board evaluation
but no director age or term limits, and (5) giving shareholders an
“orderly” voice.
We hope that the growing
recognition of the analytical and methodological defects in the
so-called empirical evidence put forward to justify activist hedge
fund attacks by Professor Bebchuk and his cohorts and the growing
recognition, not just in the business community, but in academia as
well, of the serious threat of activism and short-termism to
employees, communities and the economy will result in further action
by responsible institutional investors to deny support to activist
hedge funds and will also result in legislative, regulatory and
judicial actions to dampen their abuses and lessen substantially their
impact.
All copyright and trademarks in content on this site are owned by
their respective owners. Other content © 2015 The President and
Fellows of Harvard College. |
|